Resveratrol promotes secretion of wound healing related growth factors of mesenchymal stem cells originated from adult and fetal tissues
Source abstract
Abstract
Non-healing wounds have demonstrated aberrant regulation of several growth factors, thus using exogenous growth factors and cytokines in the clinical setting may improve the outcomes of non-healing wounds. Mesenchymal stem cells (MSCs) are the source of growth factors that show beneficial effect in promoting impaired wound healing. Certain culture condition should be developed to stimulate growth factor secretion from stem cell. Resveratrol, a small molecule found to increase MSCs therapeutic effectiveness. This study aims to investigate the effect of RV on secretion of wound healing related growth factors. We isolated and characterised MSCs from wharton's jelly (WJ), amniotic membrane (AM), and adipose tissue. We treated MSCs with serum deprived medium (SDM) supplemented with RV at 0.1 µM, 0.5 µM, 0.8 µM concentration. Our study revealed that RV at 0.1 µM was more effective to increase cell proliferation rate. Resveratrol at 0.1 µM promoted EGF, HGF, PDGF, and TGF-β1 secretion from MSCs. AD-MSCs showed the greatest response to RV stimulation in the term of cell proliferation and growth factors secretion. As conclusion, RV can facilitate cell proliferation and wound healing related growth factors secretion at dosage dependent manner.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Mesenchymal stem cell research · Reconstructive Surgery and Microvascular Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Dermatovenerology, Faculty of Medicine Universitas Airlangga/Dr Soetomo, General Academic Hospital
Department of Ophthalmology, Faculty of Medicine Universitas Airlangga/Dr Soetomo, General Academic Hospital
Department of Dermatovenerology, Faculty of Medicine Universitas Gadjah Mada/Dr Sardjito, General Academic Hospital
Stem Cell Research and Development Center, Universitas Airlangga
References (37)
Show source-provided references
1. 10.12968/jowc.2009.18.4.4160710.12968/jowc.2009.18.4.41607 ↗
2. 10.1097/01.ASW.0000418541.31366.a310.1097/01.ASW.0000418541.31366.a3 ↗
3. 10.1016/j.mad.2017.11.00410.1016/j.mad.2017.11.004 ↗
4. 10.4103/ijd.IJD_6_1710.4103/ijd.IJD_6_17 ↗
5. 10.1111/j.1532-950X.2009.00585.x10.1111/j.1532-950X.2009.00585.x ↗
6. 10.5966/sctm.2011-001810.5966/sctm.2011-0018 ↗
7. 10.1111/wrr.1217310.1111/wrr.12173 ↗
8. 10.1111/j.1524-475X.2008.00410.x10.1111/j.1524-475X.2008.00410.x ↗
9. 10.1186/s41038-019-0148-110.1186/s41038-019-0148-1 ↗
10. 10.1159/00037404910.1159/000374049 ↗
11. 10.1089/wound.2013.047310.1089/wound.2013.0473 ↗
12. 10.1016/j.bbrep.2018.10.00710.1016/j.bbrep.2018.10.007 ↗
13. 10.1371/journal.pone.003716210.1371/journal.pone.0037162 ↗
14. 10.1016/j.ejcb.2017.08.00210.1016/j.ejcb.2017.08.002 ↗
15. 10.4236/jbise.2012.51007110.4236/jbise.2012.510071 ↗
16. 10.3390/ijms1907189710.3390/ijms19071897 ↗
17. Komaratih E, Rindiastuti Y, Wirohadidjojo YW, Dinaryati A, et al. The resveratrol increase of hepatocyte growth factor (HGF) and epidermal growth factor (EGF) levels in wharton’s jelly mesenchymal stem cells (WJ-MSCs) secretome: Toward cell free therapy in dry eye disease (DED). Biochem Cell Arch. 2019;19(2):1–9.
18. 10.1002/stem.181110.1002/stem.1811 ↗
19. 10.14348/molcells.2016.234510.14348/molcells.2016.2345 ↗
20. 10.1155/2015/83109510.1155/2015/831095 ↗
21. 10.1177/096368971880741010.1177/0963689718807410 ↗
22. 10.1016/j.biomaterials.2016.03.02010.1016/j.biomaterials.2016.03.020 ↗
23. 10.1016/j.stem.2013.08.00210.1016/j.stem.2013.08.002 ↗
24. 10.7150/thno.2362010.7150/thno.23620 ↗
25. 10.3346/jkms.2010.25.4.58910.3346/jkms.2010.25.4.589 ↗
26. 10.1242/jcs.0061010.1242/jcs.00610 ↗
27. Zhang R, Yin L, Zhang B, et al. H. Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death Dis. 2018;9(965):1–13.
28. 10.1016/S0002-9440(10)63754-610.1016/S0002-9440(10)63754-6 ↗
29. 10.1016/j.cardiores.2004.12.00210.1016/j.cardiores.2004.12.002 ↗
30. 10.2217/rme.14.5410.2217/rme.14.54 ↗
31. 10.1002/jcb.2562910.1002/jcb.25629 ↗
32. 10.1002/jmv.2503410.1002/jmv.25034 ↗
33. 10.5021/ad.2014.26.1.110.5021/ad.2014.26.1.1 ↗
34. Murphy PS, Evans GR. Advances in wound healing: a review of current wound healing products. Plast Surg Int. 2012;2012:190436
35. 10.1016/j.jconrel.2011.07.00410.1016/j.jconrel.2011.07.004 ↗
36. Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-beta family in wound healing, burns and scarring: a review. Int J Burns Trauma. 2012;2(1):18–28.
37. 10.1177/153473460629841610.1177/1534734606298416 ↗